663
Views
5
CrossRef citations to date
0
Altmetric
Articles

AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial

ORCID Icon, , , , , , , , , , , , , , , , & show all
Pages 1871-1878 | Received 21 Nov 2021, Accepted 25 Jun 2022, Published online: 18 Jul 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tian Huan, Bugao Guan, Hongbo Li, Xiu Tu, Chi Zhang & Bin Tang. (2023) Principles and current clinical landscape of NK cell engaging bispecific antibody against cancer. Human Vaccines & Immunotherapeutics 19:2.
Read now
Karan L. Chohan & Stephen M. Ansell. (2022) The broader prospects for bispecifics in Hodgkin lymphoma. Leukemia & Lymphoma 63:8, pages 1777-1779.
Read now

Articles from other publishers (3)

Till Braun & Alexandra Schrader. (2023) Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies. Cancers 15:9, pages 2532.
Crossref
Alessia Floerchinger, Jessica E. Klein, Maximiliane S. C. Finkbeiner, Theresa E. Schäfer, Gwendolin Fuchs, Johannes Doerner, Hubert Zirngibl, Maximilian Ackermann, Hans M. Kvasnicka, Kerry A. Chester, Dirk Jäger, Claudia R. Ball, Guy Ungerechts & Christine E. Engeland. (2023) A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors. Cell Death & Disease 14:2.
Crossref
H. Miles Prince, Martin Hutchings, Eva Domingo-Domenech, Dennis A. Eichenauer & Ranjana Advani. (2022) Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives. Annals of Hematology 102:1, pages 13-29.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.